|
CA2768444A1
(en)
*
|
2009-07-17 |
2011-01-20 |
Rigshospitalet |
Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2857499A1
(en)
|
2010-10-01 |
2015-04-08 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
PT3682905T
(pt)
|
2011-10-03 |
2022-04-07 |
Modernatx Inc |
Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
|
|
ES2923757T3
(es)
|
2011-12-16 |
2022-09-30 |
Modernatx Inc |
Composiciones de ARNm modificado
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
PT2922554T
(pt)
|
2012-11-26 |
2022-06-28 |
Modernatx Inc |
Arn modificado nas porções terminais
|
|
ES2967701T3
(es)
*
|
2013-03-15 |
2024-05-03 |
Translate Bio Inc |
Mejora sinergística de la entrega de ácidos nucleicos mediante formulaciones mezcladas
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
JP2014227338A
(ja)
*
|
2013-05-17 |
2014-12-08 |
キヤノン株式会社 |
インドシアニングリーン含有粒子およびその製造方法
|
|
AU2014293013A1
(en)
|
2013-07-26 |
2016-03-17 |
Race Oncology Ltd. |
Combinatorial methods to improve the therapeutic benefit of bisantrene
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
DK3138555T3
(da)
|
2014-04-30 |
2020-12-14 |
Fujifilm Corp |
Liposomsammensætning og fremgangsmåde til fremstilling heraf
|
|
WO2016131006A1
(en)
*
|
2015-02-13 |
2016-08-18 |
Orient Pharma Inc. |
Compositions and methods of tumor treatment utilizing nanoparticles
|
|
WO2016141167A1
(en)
|
2015-03-03 |
2016-09-09 |
Cureport, Inc. |
Combination liposomal pharmaceutical formulations
|
|
CA2977397A1
(en)
|
2015-03-03 |
2016-09-09 |
Cureport, Inc. |
Dual loaded liposomal pharmaceutical formulations
|
|
JP2018510859A
(ja)
*
|
2015-03-17 |
2018-04-19 |
レオン−ナノドラッグズ ゲーエムベーハー |
安定化されたボロン酸化合物を含むナノ粒子
|
|
WO2016161428A1
(en)
*
|
2015-04-02 |
2016-10-06 |
The Research Foundation For The State University Of New York |
Serum-stable compositions and methods for light-triggered release of materials
|
|
HRP20220156T1
(hr)
|
2015-09-17 |
2022-04-15 |
Modernatx, Inc. |
Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
|
|
JP6602886B2
(ja)
*
|
2015-11-02 |
2019-11-06 |
富士フイルム株式会社 |
ゲムシタビンリポソーム組成物を含む腫瘍治療剤およびキット
|
|
EP3377043A4
(en)
*
|
2015-11-20 |
2019-06-26 |
The Regents of The University of California |
DEVICABLE NANOSCAL CARRIER (DNVS) FOR ADMINISTRATION THROUGH THE BLOOD-BRAIN-BARRIER, MICE AND SKIN
|
|
DK3386484T3
(da)
|
2015-12-10 |
2022-07-04 |
Modernatx Inc |
Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler
|
|
US20200282101A1
(en)
*
|
2015-12-18 |
2020-09-10 |
Medigear International Corporation |
Biodegradable tumor sealant
|
|
RS63051B1
(sr)
|
2015-12-22 |
2022-04-29 |
Modernatx Inc |
Jedinjenja i kompozicije za intracelularnu isporuku agenasa
|
|
KR101630397B1
(ko)
*
|
2015-12-31 |
2016-06-24 |
한국과학기술원 |
항암제-인도시아닌 그린-리포좀 복합체를 포함하는 암 치료용 조성물
|
|
WO2017142876A1
(en)
|
2016-02-15 |
2017-08-24 |
University Of Georgia Research Foundation, Inc. |
lPA-3-LOADED LIPOSOMES AND METHODS OF USE THEREOF
|
|
KR102483033B1
(ko)
|
2016-05-16 |
2022-12-30 |
액세스 투 어드밴스드 헬스 인스티튜트 |
페길화된 리포솜 및 이의 용도
|
|
EP3538067A1
(en)
|
2016-11-08 |
2019-09-18 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
CN106474057A
(zh)
*
|
2016-12-02 |
2017-03-08 |
中国药科大学 |
一种奥沙利铂热敏长循环脂质体的蔗糖溶液制剂及其制备方法
|
|
CA3050686A1
(en)
*
|
2017-01-18 |
2018-07-26 |
Temasek Life Sciences Laboratory Limited |
Hyperstabilized liposomes increase targeting of mitotic cells
|
|
RS63953B1
(sr)
|
2017-03-15 |
2023-02-28 |
Modernatx Inc |
Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava
|
|
JP7332478B2
(ja)
|
2017-03-15 |
2023-08-23 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子製剤
|
|
WO2018170322A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
|
CN110662532A
(zh)
|
2017-04-03 |
2020-01-07 |
加利福尼亚大学董事会 |
用于跨血脑屏障、透粘膜和经皮药物递送的可变形的纳米级媒介物(dnvs)
|
|
EP3638678B1
(en)
|
2017-06-14 |
2025-12-03 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
MA49421A
(fr)
|
2017-06-15 |
2020-04-22 |
Modernatx Inc |
Formulations d'arn
|
|
US10925831B2
(en)
*
|
2017-08-28 |
2021-02-23 |
Wake Forest University |
Liposomal formulations of platinum-acridine anticancer agents and methods thereof
|
|
MX2020002348A
(es)
|
2017-08-31 |
2020-10-08 |
Modernatx Inc |
Métodos de elaboración de nanopartículas lipídicas.
|
|
US11110060B2
(en)
*
|
2017-10-25 |
2021-09-07 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Compositions and methods for delivering pharmaceutical agents
|
|
US10606661B2
(en)
*
|
2017-12-15 |
2020-03-31 |
Rubrik, Inc. |
On-demand provisioning of customized developer environments
|
|
EP3731846A4
(en)
|
2017-12-29 |
2022-03-02 |
Wayne State University |
DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF INFECTION
|
|
FI3811949T3
(fi)
|
2018-06-20 |
2024-09-13 |
Fujifilm Corp |
Liposomikoostumukseen kapseloitua gemsitabiinia ja immuunitarkistuspistesalpaajaa käsittävä yhdistelmälääke
|
|
US12151029B2
(en)
|
2018-09-19 |
2024-11-26 |
Modernatx, Inc. |
PEG lipids and uses thereof
|
|
CN112996854B
(zh)
|
2018-09-19 |
2024-08-30 |
摩登纳特斯有限公司 |
高纯度peg脂质和其用途
|
|
EP3853202A1
(en)
|
2018-09-19 |
2021-07-28 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
US12090235B2
(en)
|
2018-09-20 |
2024-09-17 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
WO2020115171A1
(en)
*
|
2018-12-06 |
2020-06-11 |
Glaxosmithkline Biologicals Sa |
Immunogenic compositions
|
|
RU2706427C1
(ru)
*
|
2018-12-27 |
2019-11-19 |
Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" |
Способ лечения онкологических заболеваний с помощью инъекций лекарственного препарата
|
|
CN113939282A
(zh)
|
2019-01-31 |
2022-01-14 |
摩登纳特斯有限公司 |
制备脂质纳米颗粒的方法
|
|
MX2021013842A
(es)
*
|
2019-05-14 |
2022-01-18 |
Pharmosa Biopharm Inc |
Composicion farmaceutica de un farmaco de acido debil y metodos de administracion.
|
|
JP7253735B2
(ja)
|
2019-07-02 |
2023-04-07 |
パナソニックＩｐマネジメント株式会社 |
通過可否判定装置、通過管理システム、通過可否判定方法、及び、コンピュータプログラム
|
|
AU2020351220A1
(en)
|
2019-09-19 |
2022-04-07 |
Modernatx, Inc. |
Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
WO2021053163A1
(en)
|
2019-09-19 |
2021-03-25 |
Danmarks Tekniske Universitet |
Immune stimulating micelle composition
|
|
EP4031524A1
(en)
|
2019-09-19 |
2022-07-27 |
ModernaTX, Inc. |
Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
US20220364139A1
(en)
*
|
2019-09-24 |
2022-11-17 |
Pataigin, Llc |
Methods for determining growth and response
|
|
CN110571005B
(zh)
*
|
2019-09-27 |
2021-01-01 |
广西科技大学 |
一种固定化金属离子-磁性脂质体及其制备方法和应用
|
|
IL300676A
(en)
*
|
2020-08-20 |
2023-04-01 |
Bionanosim Bns Ltd |
A lipid system for the administration of OCA
|
|
KR102560135B1
(ko)
|
2020-12-04 |
2023-07-27 |
가톨릭대학교 산학협력단 |
표적 치료제의 효과적인 전달을 위한 다기능성 리포좀 조성물
|
|
EP4291898A1
(en)
|
2021-02-12 |
2023-12-20 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Method for prognosis and treating a patient suffering from cancer
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
AU2021433065A1
(en)
|
2021-03-08 |
2023-09-28 |
Eyegene Inc. |
Vaccine composition for preventing sars-cov-2
|
|
US20240108545A1
(en)
|
2022-10-03 |
2024-04-04 |
West Pharmaceutical Services, Inc. |
Methods and adapters for mixing pharmaceutical complexes
|